VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model-Reference-Cited by-同舟云学术

VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model

Published:2010-01-01 Issue:1 Volume:59 Page:17-24
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Tripathi Ranjana¹,Singh Naorem Santa¹,Dureja Chetna¹,Haldar Swati¹,Mondal Alok K.¹,Raychaudhuri Saumya¹

Affiliation:

1. Institute of Microbial Technology, Molecular Biology Division, Chandigarh, Council of Scientific and Industrial Research (CSIR), New Delhi 160036, India

Abstract

VopF, a type III effector protein, has been identified as a contributory factor to the intestinal colonization of type III secretion system-positive, non-O1, non-O139 Vibrio cholerae strains. To gain more insight into the function of VopF, a yeast model was developed. Using this model, it was found that ectopic expression of VopF conferred toxicity in yeast.

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference27 articles.

1. Identification of small molecule inhibitors of Pseudomonas aeruginosa Exoenzyme S using a yeast phenotypic screen;Arnoldo;PLoS Genet,2008

2. The genome of non-O1 Vibrio cholerae NRT 36S demonstrates the presence of pathogenic mechanisms that are distinct from O1 Vibrio cholerae;Chen;Infect Immun,(2007

3. EPEC's weapons of mass subversion;Dean;Curr Opin Microbiol,2005

4. Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system;Dziejman;Proc Natl Acad Sci U S A,2005

5. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model;Hassane;Infect Immun,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-Ascorbic Acid Restricts Vibrio cholerae Survival in Various Growth Conditions;Microorganisms;2024-02-29

2. Insight into novel inhibitors fromSterculia urensagainst Cholera via pharmacoinformatics and molecular dynamics simulation approaches;Journal of Biomolecular Structure and Dynamics;2023-09-05

3. L-Ascorbic acid restrictsVibrio choleraesurvival in various growth conditions;2023-04-07

4. Combined administration of novobiocin and apomorphine mitigates cholera toxin mediated cellular toxicity;2022-12-14

5. VopE, a Vibrio cholerae Type III Effector, Attenuates the Activation of CWI-MAPK Pathway in Yeast Model System;Frontiers in Cellular and Infection Microbiology;2017-03-20